
|Videos|February 22, 2021
ASCO GI 2021 OS Update: IMbrave150
Author(s)Targeted Oncology
Ruth He, MD, discusses the current treatment options for unresectable hepatocellular carcinoma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D–Mutated NSCLC
2
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
3
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
4
FDA Grants Fast Track Designation to TER-2013 for Advanced Breast Cancer
5



































